Mark Wilterding - 05 Sep 2026 Form 4 Insider Report for RxSight, Inc. (RXST)

Reporting relationship: Chief Financial Officer
Issuer ticker: RXST
Reported as of: 05 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Sep 2026, 20:55:54 UTC
Prior SEC filing: 02 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Jim Schindler, as Attorney-in-Fact

Key filing fact

Mark Wilterding filed Form 4 for RxSight, Inc. (RXST) on 09 Sep 2026.

Key facts

This page summarizes Mark Wilterding's Form 4 filing for RxSight, Inc. (RXST).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 09 Sep 2026, 20:55.

Change

Previous filing in this sequence was filed on 02 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002107187 Primary reporting owner

Wilterding Mark

Relationship: Chief Financial Officer
Address: 100 COLUMBIA, ALISO VIEJO
Signature: /s/ Jim Schindler, as Attorney-in-Fact
Signature date: 09 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXST transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -258,770
Change %: -100%
Price
Shares after: 0
Date: 05 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 258,770
Exercise price: $10.09
Footnotes: F1, F2

RXST transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +258,770
Change %
Price
Shares after: 258,770
Date: 05 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 258,770
Exercise price: $6.38
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of January 11, 2026 (the "Vesting Commencement Date"), and the remaining shares subject to the options shall vesting equally monthly on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) over the following three years, such that all of the shares subject to the option shall be fully vested four years from the Vesting Commencement Date.

Footnote F2

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.375 per share.

Footnote F3

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.